MML Investors Services’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
PHS
OCA
BI
IFA
BC
PAMS
MML Investors Services's RCUS Position: Q4 2022 in Review
MML Investors Services sold out of Arcus Biosciences (RCUS) in Q4 2022, closing a stake of 7,741 shares — an estimated $203K sold.
MML Investors Services first reported a position in RCUS in Q2 2018 and held it in 18 quarters. The position peaked at $720K in Q3 2018. 200 funds tracked by Wall St. Rank hold RCUS as of Q4 2022.
- MML Investors Services reported no remaining Arcus Biosciences position as of Q4 2022 after selling out during the quarter.
- MML Investors Services sold 7,741 Arcus Biosciences shares in Q4 2022, an estimated $203K.
- MML Investors Services first reported a position in Arcus Biosciences in Q2 2018 and held it in 18 quarters.
- MML Investors Services's Arcus Biosciences position peaked at $720K in Q3 2018.
- 200 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2022.
Based on MML Investors Services's 13F filing for Q4 2022, filed 13 Feb 2023.